You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 22, December 10, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (11)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Medical Practice
 •Medical Practice, Other
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Genetic Disorders
 •Genetics, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

An Unwelcome Side Effect of Direct-to-Consumer Personal Genome Testing

Raiding the Medical Commons

Amy L. McGuire, JD, PhD; Wylie Burke, MD, PhD

JAMA. 2008;300(22):2669-2671.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

It is now possible for individuals to learn about their genetic susceptibility to dozens of common and complex disorders, such as coronary artery disease, diabetes, obesity, prostate cancer, and Alzheimer disease, without ever seeing a physician. Direct-to-consumer personal genome testing companies hope to empower consumers to take control of their health by providing tailored assessments of genetic risk based on reported associations between genomic variation and susceptibility to disease.

Several states limit or forbid this practice as a violation of state law that requires the appropriate involvement of a licensed physician when providing medical diagnostic information.1 Personal genome testing companies claim that their services are for informational and educational purposes only. They warn consumers that the information should not be used for diagnosis, treatment, or health ascertainment purposes and direct them to their physicians if they have questions or concerns about . . . [Full Text of this Article]

Raiding the Medical Commons

Author Affiliations: Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas (Dr McGuire); and Department of Bioethics and Humanities, University of Washington, Seattle (Dr Burke).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A practical guide to interpretation and clinical application of personal genomic screening
Edelman and Eng
BMJ 2009;339:b4253-b4253.
FULL TEXT  

Currents in Contemporary Ethics: Direct-to-Consumer Genetic Testing: Is It the Practice of Medicine?
Marietta and McGuire
J Law Med Ethics 2009;37:369-374.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.